Pa. Superior Court Won't Rehear Reglan Preemption Appeal
Pharmaceutical companies looking to dodge thousands of state law claims for alleged injuries related to generic versions of the digestive drug Reglan were dealt a loss Wednesday after the Pennsylvania Superior...To view the full article, register now.
Already a subscriber? Click here to view full article